CD8A and COVID-19: Stimulation of PBMC collected 14 days post inclusion with the different peptide pools led to consistent detection of CD4+ and/or CD8+ SARS-CoV-2-specific T cells in COVID-19 ARDS patients (Fig. 2, Fig. 3).